about
Conservation and variability of dengue virus proteins: implications for vaccine designMemory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individualsA live, attenuated recombinant West Nile virus vaccine.T-cell memory responses elicited by yellow fever vaccine are targeted to overlapping epitopes containing multiple HLA-I and -II binding motifsRecommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers.Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responsesProteome-wide analysis of HIV-specific naive and memory CD4(+) T cells in unexposed blood donors.The identification of HLA class II-restricted T cell epitopes to vaccinia virus membrane proteins.Epitope mapping of HIV-specific CD8+ T cell responses by multiple immunological readouts reveals distinct specificities defined by function.Transmitted virus fitness and host T cell responses collectively define divergent infection outcomes in two HIV-1 recipients.Identification of conserved and HLA promiscuous DENV3 T-cell epitopes.Broad HIV epitope specificity and viral inhibition induced by multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adultsPooled-Peptide Epitope Mapping Strategies Are Efficient and Highly Sensitive: An Evaluation of Methods for Identifying Human T Cell Epitope Specificities in Large-Scale HIV Vaccine Efficacy Trials.Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection.West Nile virus T-cell ligand sequences shared with other flaviviruses: a multitude of variant sequences as potential altered peptide ligandsEndogenous antigen processing drives the primary CD4+ T cell response to influenza.Vertical T cell immunodominance and epitope entropy determine HIV-1 escape.Short communication: broader T cell responses directed against human immunodeficiency virus type 1 in infected Chinese individuals through blood-borne transmission in comparison with mucosal transmissionRole of T-cell epitope-based vaccine in prophylactic and therapeutic applications.Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoire.A novel approach to evaluate the immunogenicity of viral antigens of clinical importance in HLA transgenic murine models.Optimizing peptide matrices for identifying T-cell antigensCharacterization of respiratory syncytial virus M- and M2-specific CD4 T cells in a murine model.The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection.T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy.Group testing for case identification with correlated responses.A DNA-based candidate HIV vaccine delivered via in vivo electroporation induces CD4 responses toward the α4β7-binding V2 loop of HIV gp120 in healthy volunteers.Modulation of immune responses - strategies for optimising vaccines.
P2860
Q24288762-28657415-80EF-4F52-81A9-ACB826155215Q24648051-8C85FB19-78A7-404D-87C9-A1499AAAB054Q27473138-48626431-06A9-40B8-BA01-AAA1FE57C348Q28485408-20893829-C45B-4C21-97A8-1B44EA55545EQ28744503-DA12F84E-EECA-407F-97D0-6843548C83E6Q28749120-707B5B70-8F9C-4AFC-ACF4-3D22D6E290AAQ33826872-88C27F0B-19FD-4E41-B9DD-E068930EB657Q34288498-DB817273-726D-4F99-AC89-DD9A40EFF990Q34487813-2F70B050-A849-4CF4-99FC-882DE9662ADAQ34874985-587F1228-3E3E-48BC-B364-0DB2CA3184B2Q35018972-15449E62-AF67-4864-84DE-2E37906E7563Q35114907-D69A55E3-88EC-48F8-AAA0-1E10D401BAD8Q35919760-59977594-4AA1-48CF-B2A3-624F560BB17CQ35970916-94248D99-0830-415A-AAD0-D169C2CE2FC8Q36155428-8855ED93-0830-42EF-A8D5-ED61D2544017Q36240012-938C313F-543C-4E89-ABA0-D79D2F18FC66Q36497283-B15AE838-9B38-4CFF-94AF-529AAF5D1610Q36509595-140B01CD-5EC3-44B3-8F2A-1C2A95D64E9CQ36795668-1C0714B9-549E-48FC-8805-60FC2F8E6241Q36846254-3CCEF71C-2445-428C-8A49-9D1C55AD9254Q36960608-9258F0AE-9ED8-4C2A-BD27-7B0B6A619F71Q36982384-FC47A933-6962-46A2-A202-33523F0C4DA9Q37192233-9F8FCCB0-45D2-4F91-9895-349F93A3D7B6Q37273195-F5DA099E-4D2B-4C2D-99E5-F403AD226E04Q41933638-51A0B4DE-B00F-40D4-AC96-76862C2EA297Q42217158-B6897850-2434-43F1-9A3C-39DCA89B7437Q42321384-4073C240-1768-48A1-9F72-518663D61A6BQ52000464-8DA14DD4-81F9-4FF0-B2CC-5652080189F0
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Optimized determination of T cell epitope responses.
@ast
Optimized determination of T cell epitope responses.
@en
type
label
Optimized determination of T cell epitope responses.
@ast
Optimized determination of T cell epitope responses.
@en
prefLabel
Optimized determination of T cell epitope responses.
@ast
Optimized determination of T cell epitope responses.
@en
P1476
Optimized determination of T cell epitope responses.
@en
P2093
Mario Roederer
Richard A Koup
P304
P356
10.1016/S0022-1759(02)00423-4
P577
2003-03-01T00:00:00Z